<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03135327</url>
  </required_header>
  <id_info>
    <org_study_id>20070492</org_study_id>
    <nct_id>NCT03135327</nct_id>
  </id_info>
  <brief_title>Clinical Applications of Advanced Ophthalmic Imaging</brief_title>
  <official_title>Clinical Applications of Advanced Ophthalmic Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study to determine the clinical application of advanced ophthalmic imaging devices such
      as optical coherence tomography (OCT), retinal function imager (RFI), slit-lamp biomicroscopy
      (SLB), PERG in diseased eyes and normal controls.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2007</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Retinal microstructure using OCT.</measure>
    <time_frame>10 years</time_frame>
    <description>Optical coherence tomography is used to measure the thickness of intraretinal layers. The measurement is in micrometer.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Retinal vasculature by optical coherence tomography angiography (OCTA)</measure>
    <time_frame>10 years</time_frame>
    <description>Retinal vascular network density in percentage.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Conjunctival vasculature by functional slit-lamp (FSLB)</measure>
    <time_frame>10 years</time_frame>
    <description>Conjunctival vascular network density in percentage.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal epithelial thickness and tear film thickness</measure>
    <time_frame>10 years</time_frame>
    <description>Corneal epithelial thickness in micrometers measured using ultra-high resolution OCT.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Retinal blood flow velocity by retinal function imager (RFI)</measure>
    <time_frame>10 years</time_frame>
    <description>Retinal blood flow velocity in mm/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Conjunctival blood flow velocity by functional slit-lamp (FSLB)</measure>
    <time_frame>10 years</time_frame>
    <description>Conjunctival blood flow velocity in mm/s</description>
  </secondary_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Multiple Sclerosis</condition>
  <condition>Dry Eye Syndromes</condition>
  <condition>Diabetic Retinopathy</condition>
  <condition>Presbyopia</condition>
  <condition>Myopia</condition>
  <condition>Dementia</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with diseases and normal controls.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Self-reported normal healthy subjects Clinical diagnosis of Alzheimer's Disease, mild
        cognitive impairment, multiple sclerosis, dry eye, myopia, diabetic.

        Who can keep the eye open for imaging.

        Exclusion Criteria: who can not read and sign the ICF.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jianhua Wang, MD, PhD</last_name>
    <phone>3054825010</phone>
    <email>jwang3@med.miami.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Bascom Palmer Eye Institute</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianhua Wang, MD, PHD</last_name>
      <phone>305-482-5010</phone>
      <email>jwang3@med.miami.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 24, 2017</study_first_submitted>
  <study_first_submitted_qc>April 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2017</study_first_posted>
  <last_update_submitted>May 7, 2018</last_update_submitted>
  <last_update_submitted_qc>May 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Jianhua (Jay) Wang, MD, PhD</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Diabetic Retinopathy</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Presbyopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

